Aspen eyes more overseas buys after recent deals pay off

South Africa-based Aspen Pharmacare, encouraged by the payoff from $2 billion worth of recent international buys, is looking for more overseas products and companies to snap up. CEO Stephen Saad tells Reuters that he's "looking the hardest" in Asia. Report